Toxic erythema as the first sign of COVID-19 infection

Clin Exp Dermatol. 2021 Jun;46(4):756-758. doi: 10.1111/ced.14571. Epub 2021 Feb 18.

Authors

M K Hunjan¹, L Zuzarte¹, A Bardhan^{1

2}, S Karim³, A H M Heagerty^{1

2}

Affiliations

¹ Department of Dermatology, Solihull Hospital, University Hospitals Birmingham NHS Trust, Birmingham, UK.
² University of Birmingham, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
³ Department of Histopathology, University Hospitals Birmingham NHS Trust, Birmingham, UK.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

COVID-19 / diagnosis
COVID-19 / pathology*
COVID-19 Nucleic Acid Testing
Dexamethasone / therapeutic use
Erythema / drug therapy
Erythema / pathology
Exanthema / drug therapy
Exanthema / pathology*
Female
Glucocorticoids / therapeutic use
Humans
Middle Aged
Radiography, Thoracic
SARS-CoV-2

Substances

Glucocorticoids
Dexamethasone